Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity
Interest in CBG (cannabigerol) has been growing in the past few years, due to its anti-inflammatory properties and other therapeutic benefits. Here we report the synthesis of three new CBG derivatives (HUM-223, HUM-233 and HUM-234) and show them to possess anti-inflammatory and analgesic properties....
Main Authors: | Natalya M. Kogan, Yarden Lavi, Louise M. Topping, Richard. O. Williams, Fiona E. McCann, Zhanna Yekhtin, Marc Feldmann, Ruth Gallily, Raphael Mechoulam |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/18/5601 |
Similar Items
-
Biotechnological Approaches on Two High CBD and CBG <i>Cannabis sativa</i> L. (Cannabaceae) Varieties: In Vitro Regeneration and Phytochemical Consistency Evaluation of Micropropagated Plants Using Quantitative <sup>1</sup>H-NMR
by: Kostas Ioannidis, et al.
Published: (2020-12-01) -
Chemotherapy‐induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol
by: Daniel I. Brierley, et al.
Published: (2019-08-01) -
Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
by: Tamara T. Lah, et al.
Published: (2021-02-01) -
A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates
by: Albert Stuart Reece, et al.
Published: (2021-02-01) -
Contemporary epidemiology of rising atrial septal defect trends across USA 1991–2016: a combined ecological geospatiotemporal and causal inferential study
by: Albert Stuart Reece, et al.
Published: (2020-11-01)